{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:10:11Z","timestamp":1744207811339,"version":"3.40.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,9]]},"DOI":"10.7759\/cureus.81956","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:35:37Z","timestamp":1744205737000},"source":"Crossref","is-referenced-by-count":0,"title":["Current Trends in Antibiotic Therapy and Resistance: A Comparative Study of Various Spectrums"],"prefix":"10.7759","author":[{"given":"Maryam","family":"Atta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeman","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amara","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samreen","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoukat","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marriam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X211069931","article-title":"Physicians under pressure: evidence from antibiotics prescribing in England","volume":"42","author":"Allen T","year":"2022","unstructured":"Allen T, Gyrd-Hansen D, Kristensen SR, Oxholm AS, Pedersen LB, Pezzino M. Physicians under pressure: evidence from antibiotics prescribing in England. Med Decis Making. 2022, 42:303-12. 10.1177\/0272989X211069931","journal-title":"Med Decis Making"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.07.016","article-title":"Targeted microbiome-sparing antibiotics","volume":"26","author":"Avis T","year":"2021","unstructured":"Avis T, Wilson FX, Khan N, Mason CS, Powell DJ. Targeted microbiome-sparing antibiotics. Drug Discov Today. 2021, 26:2198-203. 10.1016\/j.drudis.2021.07.016","journal-title":"Drug Discov Today"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ447","article-title":"Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing","volume":"61","author":"Banerjee R","year":"2015","unstructured":"Banerjee R, Teng CB, Cunningham SA, et al.. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015, 61:1071-80. 10.1093\/cid\/civ447","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13006","article-title":"Diabetic foot infection: antibiotic therapy and good practice recommendations","volume":"71","author":"Barwell ND","year":"2017","unstructured":"Barwell ND, Devers MC, Kennon B, et al.. Diabetic foot infection: antibiotic therapy and good practice recommendations. Int J Clin Pract. 2017, 71:10.1111\/ijcp.13006","journal-title":"Int J Clin Pract"},{"key":"ref5","article-title":"Prescriptions of broad-spectrum antibiotics to outpatients do not match increased prevalence and antibiotic resistance of respiratory pathogens in Bavaria","volume":"58","author":"Borgmann S","year":"2009","unstructured":"Borgmann S, Jakobiak T, Gruber H, Schr\u00f6der H, Sagel U. Prescriptions of broad-spectrum antibiotics to outpatients do not match increased prevalence and antibiotic resistance of respiratory pathogens in Bavaria. Pol J Microbiol. 2009, 58:105-10.","journal-title":"Pol J Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11538-022-01013-7","article-title":"A refunding scheme to incentivize narrow-spectrum antibiotic development","volume":"84","author":"B\u00f6ttcher L","year":"2022","unstructured":"B\u00f6ttcher L, Gersbach H. A refunding scheme to incentivize narrow-spectrum antibiotic development. Bull Math Biol. 2022, 84:59. 10.1007\/s11538-022-01013-7","journal-title":"Bull Math Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201606-486BC","article-title":"Broad- versus narrow-spectrum oral antibiotic transition and outcomes in health care-associated pneumonia","volume":"14","author":"Buckel WR","year":"2017","unstructured":"Buckel WR, Stenehjem E, Sorensen J, Dean N, Webb B. Broad- versus narrow-spectrum oral antibiotic transition and outcomes in health care-associated pneumonia. Ann Am Thorac Soc. 2017, 14:200-5. 10.1513\/AnnalsATS.201606-486BC","journal-title":"Ann Am Thorac Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262090-00001","article-title":"Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to beta-lactams","volume":"62","author":"Carbon C","year":"2002","unstructured":"Carbon C, Isturiz R. Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to beta-lactams. Drugs. 2002, 62:1289-94. 10.2165\/00003495-200262090-00001","journal-title":"Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2024.109203","article-title":"The straight and narrow: a game theory model of broad- and narrow-spectrum empiric antibiotic therapy","volume":"372","author":"Diamant M","year":"2024","unstructured":"Diamant M, Obolski U. The straight and narrow: a game theory model of broad- and narrow-spectrum empiric antibiotic therapy. Math Biosci. 2024, 372:109203. 10.1016\/j.mbs.2024.109203","journal-title":"Math Biosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)17907-0","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens H","year":"2005","unstructured":"Goossens H, Ferech M, Vander Stichele R, et al.. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005, 365:579-87. 10.1016\/s0140-6736(05)17907-0","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27628-x","article-title":"Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis","volume":"13","author":"Hahn A","year":"2023","unstructured":"Hahn A, Burrell A, Chaney H, et al.. Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis. Sci Rep. 2023, 13:1217. 10.1038\/s41598-023-27628-x","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00068-019-01182-6","article-title":"The effect of early broad-spectrum versus delayed narrow-spectrum antibiotic therapy on the primary cure rate of acute infection after osteosynthesis","volume":"46","author":"Hellebrekers P","year":"2020","unstructured":"Hellebrekers P, Verhofstad MH, Leenen LP, Varol H, van Lieshout EM, Hietbrink F. The effect of early broad-spectrum versus delayed narrow-spectrum antibiotic therapy on the primary cure rate of acute infection after osteosynthesis. Eur J Trauma Emerg Surg. 2020, 46:1341-50. 10.1007\/s00068-019-01182-6","journal-title":"Eur J Trauma Emerg Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1039\/d0nr04886k","article-title":"Supramolecular antibiotics: a strategy for conversion of broad-spectrum to narrow-spectrum antibiotics for Staphylococcus aureus","volume":"12","author":"Koyasseril-Yehiya TM","year":"2020","unstructured":"Koyasseril-Yehiya TM, Garc\u00eda-Heredia A, Anson F, Rangadurai P, Siegrist MS, Thayumanavan S. Supramolecular antibiotics: a strategy for conversion of broad-spectrum to narrow-spectrum antibiotics for Staphylococcus aureus. Nanoscale. 2020, 12:20693-8. 10.1039\/d0nr04886k","journal-title":"Nanoscale"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2012.08.006","article-title":"Choosing optimal antimicrobial therapies","volume":"96","author":"Lynch TJ","year":"2012","unstructured":"Lynch TJ. Choosing optimal antimicrobial therapies. Med Clin North Am. 2012, 96:1079-94. 10.1016\/j.mcna.2012.08.006","journal-title":"Med Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000819","article-title":"Choosing antibiotic therapy for severe community-acquired pneumonia","volume":"35","author":"Martin-Loeches I","year":"2022","unstructured":"Martin-Loeches I, Garduno A, Povoa P, Nseir S. Choosing antibiotic therapy for severe community-acquired pneumonia. Curr Opin Infect Dis. 2022, 35:133-9. 10.1097\/QCO.0000000000000819","journal-title":"Curr Opin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.1c00004","article-title":"Design and syntheses of new antibiotics inspired by nature's quest for iron in an oxidative climate","volume":"54","author":"Miller MJ","year":"2021","unstructured":"Miller MJ, Liu R. Design and syntheses of new antibiotics inspired by nature's quest for iron in an oxidative climate. Acc Chem Res. 2021, 54:1646-61. 10.1021\/acs.accounts.1c00004","journal-title":"Acc Chem Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux022","article-title":"Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology","volume":"41","author":"Mills S","year":"2017","unstructured":"Mills S, Ross RP, Hill C. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology. FEMS Microbiol Rev. 2017, 41:S129-53. 10.1093\/femsre\/fux022","journal-title":"FEMS Microbiol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116810","article-title":"Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics","volume":"176","author":"Panjla A","year":"2024","unstructured":"Panjla A, Kaul G, Shukla M, et al.. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics. Biomed Pharmacother. 2024, 176:116810. 10.1016\/j.biopha.2024.116810","journal-title":"Biomed Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000622","article-title":"Carbapenem use in critically ill patients","volume":"33","author":"Patrier J","year":"2020","unstructured":"Patrier J, Timsit JF. Carbapenem use in critically ill patients. Curr Opin Infect Dis. 2020, 33:86-91. 10.1097\/QCO.0000000000000622","journal-title":"Curr Opin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/chem.201904053","article-title":"The nargenicin family of oxa-bridged macrolide antibiotics","volume":"26","author":"Pidot SJ","year":"2020","unstructured":"Pidot SJ, Rizzacasa MA. The nargenicin family of oxa-bridged macrolide antibiotics. Chemistry. 2020, 26:2780-92. 10.1002\/chem.201904053","journal-title":"Chemistry"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.12.005","article-title":"Physicians' attitudes, knowledge, and practices regarding antibiotic prescriptions","volume":"32","author":"Rahbi FA","year":"2023","unstructured":"Rahbi FA, Salmi IA, Khamis F, Balushi ZA, Pandak N, Petersen E, Hannawi S. Physicians' attitudes, knowledge, and practices regarding antibiotic prescriptions. J Glob Antimicrob Resist. 2023, 32:58-65. 10.1016\/j.jgar.2022.12.005","journal-title":"J Glob Antimicrob Resist"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05950-6","article-title":"Bloodstream infections in critically ill patients: an expert statement","volume":"46","author":"Timsit JF","year":"2020","unstructured":"Timsit JF, Rupp\u00e9 E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020, 46:266-84. 10.1007\/s00134-020-05950-6","journal-title":"Intensive Care Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2017.06.013","article-title":"Childhood community-acquired pneumonia: a review of etiology- and antimicrobial treatment studies","volume":"26","author":"Tramper-Stranders GA","year":"2018","unstructured":"Tramper-Stranders GA. Childhood community-acquired pneumonia: a review of etiology- and antimicrobial treatment studies. Paediatr Respir Rev. 2018, 26:41-8. 10.1016\/j.prrv.2017.06.013","journal-title":"Paediatr Respir Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2011.12.003","article-title":"Antibiotic use and misuse in the neonatal intensive care unit","volume":"39","author":"Tripathi N","year":"2012","unstructured":"Tripathi N, Cotten CM, Smith PB. Antibiotic use and misuse in the neonatal intensive care unit. Clin Perinatol. 2012, 39:61-8. 10.1016\/j.clp.2011.12.003","journal-title":"Clin Perinatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.09.014","article-title":"Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa","volume":"47","author":"Vestergaard M","year":"2016","unstructured":"Vestergaard M, Paulander W, Marvig RL, et al.. Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents. 2016, 47:48-55. 10.1016\/j.ijantimicag.2015.09.014","journal-title":"Int J Antimicrob Agents"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2022.102203","article-title":"Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics","volume":"70","author":"Vita NA","year":"2022","unstructured":"Vita NA, Anderson SM, LaFleur MD, Lee RE. Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics. Curr Opin Microbiol. 2022, 70:102203. 10.1016\/j.mib.2022.102203","journal-title":"Curr Opin Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106161","article-title":"No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia","volume":"88","author":"Wei J","year":"2024","unstructured":"Wei J, Uppal A, Nganjimi C, et al.. No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia. J Infect. 2024, 88:106161. 10.1016\/j.jinf.2024.106161","journal-title":"J Infect"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b19658","article-title":"Multivalent aminosaccharide-based gold nanoparticles as narrow-spectrum antibiotics in vivo","volume":"11","author":"Yang X","year":"2019","unstructured":"Yang X, Wei Q, Shao H, Jiang X. Multivalent aminosaccharide-based gold nanoparticles as narrow-spectrum antibiotics in vivo. ACS Appl Mater Interfaces. 2019, 11:7725-30. 10.1021\/acsami.8b19658","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2016.09.014","article-title":"Bacterial fatty acid metabolism in modern antibiotic discovery","volume":"1862","author":"Yao J","year":"2017","unstructured":"Yao J, Rock CO. Bacterial fatty acid metabolism in modern antibiotic discovery. Biochim Biophys Acta Mol Cell Biol Lipids. 2017, 1862:1300-9. 10.1016\/j.bbalip.2016.09.014","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2004.0214","article-title":"Combating antibiotic resistance","volume":"135","year":"2004","unstructured":"Combating antibiotic resistance. J Am Dent Assoc. 2004, 135.484-7. 10.14219\/jada.archive.2004.0214","journal-title":"J Am Dent Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/345348-current-trends-in-antibiotic-therapy-and-resistance-a-comparative-study-of-various-spectrums","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:35:38Z","timestamp":1744205738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/345348-current-trends-in-antibiotic-therapy-and-resistance-a-comparative-study-of-various-spectrums"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.81956","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,9]]}}}